E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/13/2019 in the Prospect News Structured Products Daily.

New Issue: GS Finance sells $881,000 autocallable notes on SPDR S&P Biotech

By Wendy Van Sickle

Columbus, Ohio, June 13 – GS Finance Corp. priced $881,000 of 0% autocallable notes due June 14, 2022 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will be guaranteed by Goldman Sachs Group, Inc.

The notes will be automatically called at par plus an annualized call premium of 11.5% if the ETF closes at or above its initial level on any annual review date.

The payout at maturity will be par plus 34.5% if the ETF finishes at or above its initial level. If the ETF declines by up to 30%, the payout will be par. Otherwise, investors will be fully exposed to the decline of the ETF from its initial level.

Goldman Sachs & Co. LLC is the underwriter.

Issuer:GS Finance Corp.
Guarantor:Goldman Sachs Group, Inc.
Issue:Autocallable ETF-linked notes
Underlying ETF:SPDR S&P Biotech ETF
Amount:$881,000
Maturity:June 14, 2022
Coupon:0%
Price:Par
Payout at maturity:If ETF finishes at or above its initial level, par plus 34.5%; if ETF declines by up to 30%, par; otherwise, full exposure to any ETF decline
Call:At par plus 11.5% a year if ETF closes at or above initial level on an annual review date
Initial level:$82.84
Pricing date:June 7
Settlement date:June 12
Underwriter:Goldman Sachs & Co. LLC
Fees:3.45%
Cusip:40056FJZ9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.